Allergy Month in Review | October 2024
In this review of the month of October, some of the most notable advancements and news in the field of allergy were highlighted.
Related Articles
Safety of sodium-glucose cotransporter-2 inhibitors for heart failure
Drawing inferences from observational data with possible confounding Heart failure is increasing in prevalence and is a major cause of morbidity and mortality worldwide,1 with…
Steris beats quarterly estimates on continued demand for medical procedures
Medical equipment maker Steris beat second-quarter profit estimates on Wednesday, on continued demand for non-urgent medical procedures that boosted sales of its surgical and examination…
Large Language Model Influence on Diagnostic Reasoning
This randomized clinical trial evaluates the diagnostic performance of physicians with use of a large language model compared with conventional resources.
McKesson raises annual profit forecast on strength in its U.S. pharma segment
Drug distributor McKesson Corp raised its annual profit forecast on Wednesday, driven by increased sales in its U.S. pharmaceuticals segment on robust demand for specialty…
Discovery of rapid COVID-19 replication mechanism could expand treatment options
Concerns about COVID-19 have significantly diminished, but researchers continue to analyze its high transmission rate, aiming to prepare for future infectious diseases. A research team…
NHS Trusts Must Improve Disciplinary Procedures
An MPS report found significant delays in processes, with detrimental impacts on mental health.
‘Dilapidated’ Peterborough surgery still closed after two years
A Peterborough councillor says the ongoing closure of a GP surgery is “unacceptable and ludicrous”.
New support after baby loss for women in Cambridge and Ely
The Perinatal Trauma and Loss Service is for women facing mental health struggles after losing a baby.
Swindon sisters raise £27k for Prospect Hospice in mum’s memory
Two sisters from Swindon set up a tribute fund after their mum died at a hospice ten years ago.
Zealand Pharma to start phase 2b trial for obesity drug candidate in Q4
Danish biotechnology company Zealand Pharma said on Thursday it expected to initiate a phase 2b trial with its obesity treatment candidate petrelintide in the fourth…